Citation Impact
Citing Papers
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
2011 Standout
Synergistic Antitumor Effects of Combined Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor Receptor-2 Targeted Therapy
2006
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
2008 Standout
CRLX101, a Nanoparticle–Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1α
2016
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models
2008 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Etoposide: four decades of development of a topoisomerase II inhibitor
1998 Standout
Hyperthermia in combined treatment of cancer
2002 Standout
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
2008 Standout
Heating the patient: a promising approach?
2002 Standout
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
2019 Standout
Anti‐tumor activity of the combination of cetuximab, an anti‐EGFR blocking monoclonal antibody and ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinases
2006
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials
2009 Standout
Longterm Effects of Hepatic Arterial Interleukin-2–based Immunochemotherapy After Potentially Curative Resection of Colorectal Liver Metastases1
1998
Cancer Statistics, 2006
2006 Standout
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
2007 StandoutNature
Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
2011 Standout
Network pharmacology: the next paradigm in drug discovery
2008 Standout
The cellular and molecular basis of hyperthermia
2002 Standout
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
1997 Standout
Anthrazykline in der Krebstherapie
1997 Standout
Angiogenesis: an organizing principle for drug discovery?
2007 Standout
Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases
2004 Standout
Treating Primary Liver Cancer with Hepatic Arterial Infusion of Floxuridine and Dexamethasone: Does the Addition of Systemic Bevacizumab Improve Results
2011
Preoperative Hyperthermia Combined with Radiochemotherapy in Locally Advanced Rectal Cancer
1998
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
2007 Standout
Lessons from phase III clinical trials on anti-VEGF therapy for cancer
2006
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
2004 Standout
VEGF receptor signalling ? in control of vascular function
2006 Standout
Role of Combined-Modality Therapy in the Management of Locally Advanced Rectal Cancer
2008
Angiogenesis in life, disease and medicine
2005 StandoutNature
Cetuximab
2005
Annual report to the nation on the status of cancer, 1975‐2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates
2009 Standout
Fluorescent Nanorods and Nanospheres for Real‐Time In Vivo Probing of Nanoparticle Shape‐Dependent Tumor Penetration
2011 StandoutNobel
Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by 18F-FDG-PET is associated with the KRAS mutation status and prognosis
2018 StandoutNobel
Definition and grading of anastomotic leakage following anterior resection of the rectum: A proposal by the International Study Group of Rectal Cancer
2009 Standout
Identification and expansion of human colon-cancer-initiating cells
2006 StandoutNature
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Epirubicin
1993
Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer
2007 Standout
Novel targets in gastric and esophageal cancer
2006
Targeting the NLRP3 inflammasome in chronic inflammatory diseases: current perspectives
2015
Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH
2014
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Strategies for optimizing combinations of molecularly targeted anticancer agents
2006
Predicting response to epidermal growth factor receptor-targeted therapy in colorectal cancer
2007
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
2013 Standout
Idarubicin
1991
Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer
1999 Standout
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
2006 Standout
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Complications after Preoperative Combined Modality Therapy and Radical Resection of Locally Advanced Rectal Cancer: A 14-Year Experience from a Specialty Service
2005
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer
2007
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
2020 Standout
Tumor Angiogenesis
2008 Standout
A phase III comparison trial of streptozotocin, mitomycin, and 5-fluorouracil with cisplatin, cytosine arabinoside, and caffeine in patients with advanced pancreatic carcinoma
1991
A Perivascular Niche for Brain Tumor Stem Cells
2007 Standout
Spectrum of Activity and Mechanism of Action of VEGF/PDGF Inhibitors
2007
Multidisciplinary approaches to intrahepatic cholangiocarcinoma
2013
Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway
2017 StandoutNobel
Magnetic fluid hyperthermia (MFH): Cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles
1999 Standout
Oral Idarubicin in Solid Tumour Chemotherapy
1995
Anthracycline analogs The past, present, and future
1986
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
2009 Standout
Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Lung Metastases
2009 Standout
High Incidence of Cetuximab-Related Infusion Reactions in Tennessee and North Carolina and the Association With Atopic History
2007
Colorectal cancer statistics, 2017
2017 Standout
Keyhole-Limpet Haemocyanin (KLH) immunotherapy of murine transitional cell carcinoma
1983
Preoperative Treatment of Rectal Cancer with Radiation, Chemotherapy and Hyperthermia: Analysis of Treatment Efficacy and Heat-Shock Response
1999
A Pilot Trial of CTLA-4 Blockade with Human Anti-CTLA-4 in Patients with Hormone-Refractory Prostate Cancer
2007 StandoutNobel
Induction of the TRPM-2 gene in cells undergoing programmed death.
1989 Standout
Resection of colorectal liver metastases
1995 Standout
Works of N. E. Kemeny being referenced
Meeting the biologic challenge of colorectal metastases
2012
Regional and Systemic Chemotherapy for Primary Hepatobiliary Cancers and for Colorectal Cancer Metastatic to the Liver
2005
Combined modality therapy of rectal cancer: decreased acute toxicity with the preoperative approach.
1992
Poly I:C immunotherapy in patients with papillomas or superficial carcinomas of the bladder.
1978
Pilot clinical trial of 5-[125I]iodo-2'-deoxyuridine in the treatment of colorectal cancer metastatic to the liver.
1996
Unexpected increased biliary toxicity when systemic bevacizumab is added to hepatic arterial infusion.
2010
Phase II evaluation of 4'-epi-doxorubicin in patients with advanced colorectal carcinoma.
1982
Is hepatic infusion of chemotherapy effective treatment for liver metastases? Yes!
1992
Randomized phase II trial of cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer
2005
A phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer
1991
Phase II evaluation of metoprine in advanced pancreatic adenocarcinoma.
1984
Phase II trial of 4-demethoxydaunorubicin in advanced colorectal carcinoma.
1984